MR Vax, Measles-Rubella
| Product Overview | |
| Generic Name | MR Vax, Measles-Rubella |
| Brand Name(s) | BioKangtai / Beijing Minhai MR Vaccine |
| Form | Vial, Lyophilized / freeze-dried live attenuated vaccine for reconstitution |
| Strength | 0.5mL |
| Therapeutic Class | Viral vaccine; live attenuated combination vaccine |
| ATC Code | J07BD53 |
| Manufacturing & Regulatory | |
| Manufacturer | Beijing Minhai Biological Technology Co., Ltd. |
| Country | Beijing, China |
| GMP Compliance | WHO-GMP |
| DMF/CEP | No public DMF number found |
| COFEPRIS | 020.000.3800.00 |
| Logistics & Export | |
| MOQ | 10,000 Single Dose Vials |
| Shelf Life | 18 to 24 months |
| Storage | 2–8 °C, protected from light, do not freeze |
| Incoterms | EXW |
| Lead Time | 4–8 weeks after confirmed PO, payment |
| Documentation | |
| Certificate of Analysis (COA) | available per released batch, |
| CTD Summary | Not publicly available |
Description
Measles and Rubella Combined Vaccine, Live is a live attenuated viral vaccine intended for active immunisation against measles and rubella
